Detalhe da pesquisa
1.
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Blood
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728430
2.
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Blood
; 141(14): 1685-1690, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608320
3.
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
Blood
; 142(19): 1633-1646, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390336
4.
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
Mol Syst Biol
; 15(5): e8339, 2019 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118277
5.
Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach.
BMC Bioinformatics
; 20(1): 737, 2019 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888467
6.
Mixed Integer Linear Programming based machine learning approach identifies regulators of telomerase in yeast.
Nucleic Acids Res
; 44(10): e93, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908654
7.
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma.
Amyloid
; 31(2): 86-94, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206120
8.
Genomic Classification and Individualized Prognosis in Multiple Myeloma.
J Clin Oncol
; 42(11): 1229-1240, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194610
9.
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
FEBS J
; 290(17): 4256-4267, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097223
10.
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
Blood Cancer J
; 13(1): 1, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599831
11.
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.
Nat Commun
; 14(1): 5011, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591845
12.
Inhibiting PI3K-AKT-mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells.
Front Oncol
; 12: 874325, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35795041
13.
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level.
Blood Adv
; 6(22): 5873-5883, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977111
14.
An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma.
Cell Death Dis
; 13(11): 969, 2022 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400754
15.
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states.
Nat Commun
; 13(1): 4517, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922426
16.
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power.
Cancers (Basel)
; 14(5)2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267575
17.
Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.
Nat Commun
; 12(1): 6960, 2021 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845188
18.
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer.
Mol Oncol
; 14(1): 129-138, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736271
19.
The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations.
Leukemia
; 37(12): 2526-2531, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845284